USD10
MNPR Ações
Sobre Monopar TherapeuticsMonopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
USD10
MNPR Ações
Sobre Monopar TherapeuticsMonopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
Estatísticas
JANELA DE NEGOCIAÇÃO
Fechado
ABRE ÀS
24 de mar. at 13:30 GMT+0
CAPITALIZAÇÃO DE MERCADO
US$ 375,96 mi
PREÇO ABERTO
Sem dados suficientes
BAIXO (1 A)
US$ 26,06
ALTO (1 A)
US$ 105,00
BAIXO (24H)
US$ 55,48
ALTO (24H)
US$ 58,30
VOLUME (24H)
US$ 24,13 mil
402.000%
Histórico de preços
Time | Price | Change |
|---|---|---|
Hoje | Sem dados suficientes | Sem dados suficientes |
1 dia | US$ 56,68 | |
1 semana | US$ 62,37 | |
1 mês | US$ 58,17 | |
1 ano | US$ 37,58 |